Categories
Weight Loss Products

NUTRAFUELS INC (OTCMKTS:NTFU) Sellers Increased Their Shorts By 192% As Of Apr 3, 2019

NUTRAFUELS INC (OTCMKTS:NTFU) had an increase of its short interest by 192%. FINRA issued in April NTFU’s total 14,600 short interest. The up change of 192% from 5,000 shares was reported. With Average volume 100,800, NTFU’s previous position will take 0 days to recover.

The stock increased 0.20% or $0.0004 during the last trading session, touching $0.1743.Currently NutraLife BioSciences, Inc. is after 0.00% change in last April 3, 2018. NTFU has 27,175 shares volume. NTFU underperformed the SP500 by 4.37%.

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products to retail and wholesale outlets.The firm is worth $19.17 million. The companyÂ’s products include sleep spray to support a healthy sleep cycle and improve the quality of restful sleep; energize spray to enhance energy, and restore vigor and vitality; and garcinia cambogia spray, an appetite and weight management spray.Last it reported negative earnings. It also offers NRG-X extreme energy spray to enhance energy and stamina; headache and pain spray to relieve headaches and pain; and hair, skin, and nails spray to nourish and encourage hair, skin, and nail growth.

Another two news for NutraLife BioSciences, Inc. (OTCMKTS:NTFU) were recently brought out by: Marketwired.com on January 29, 2018 with title “NutraFuels (NTFU) Files its Application to Up List to the OTCQB OTC Market – Marketwired”. The other Globenewswire.com‘s article was titled “Freedom Leaf Inc. Announces National Distribution Agreement Other OTC:FRLF – GlobeNewswire” and brought out on February 28, 2018.


Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.


Categories
Weight Loss Products

Global Weight Loss Dietary Supplements Market during the Forecast Period 2017 – 2026

As per the latest study by Persistence Market Research (PMR), the global weight loss dietary supplements market is anticipated to witness healthy growth. The market is likely to register 6.0% CAGR throughout the forecast period 2017-2026. The global weight loss dietary supplements market is also estimated to bring in US$ 37,177.6 million revenue by 2026 end.

With obesity becoming a global health concern, weight loss continues to be one of the most focused areas. Hence, increasing number of companies are coming up with the new products in weight loss supplements. The increasing consumption and demand for weight loss dietary supplements, regulations on the production of these supplements along with ingredients used are also gaining traction in various countries. The government in various countries are also focusing on the quality and quantity of ingredients used and if any of these ingredients can have severe side-effects, affecting the health of the consumers negatively.

Increasing use of Natural and Organic Ingredients in the Weight Loss Dietary Supplements

The negative effects of being obese and overweight are resulting in the increasing use of weight management products. Consumers are also adopting weight loss supplements in forms of pill, liquid, and powder. Hence, with the increase in the use of these supplements, manufacturers are also trying to produce safer products, thereby using organic and natural ingredients and plant-based ingredients. Among various ingredients, green tea extract is considered as one of the most popular and safest ingredients in the weight loss dietary supplements. Similarly, Garcinia cambogia is also being considered as an ingredient in the weight loss supplements. However, these ingredients have been reported to have adverse effects like a headache, constipation, UTI. Hence, there has been an increase in the investment in the research on other organic ingredients that can be used to produce weight loss supplements.

Global Weight Loss Dietary Supplements Market: Segmental Insights

The global weight loss dietary supplements market includes various segments such as end-user, form, ingredients, distribution channel, and region. Based on the form, the market is categorized into powder, liquid, and soft gell/pills. Soft gell/pills are expected to dominate the market during the forecast period. By the end of 2026, soft gell/pills are expected to exceed US$ 18,500 million revenue.

Based on the end-user, the segment consists of men, women and senior citizen. Among these, women are expected to be the largest users of weight loss dietary supplements. Women segment as the end-user is estimated to create an incremental opportunity of more than US$ 7,900 million between 2017 and 2026.

By Distribution Channel, pharmacies drug store is expected to emerge as the largest distribution channel for the weight loss dietary supplements. Pharmacies drug store is estimated to account for more than one-third of the revenue share by the end of 2017.

A sample of this report is available upon request @  https://www.persistencemarketresearch.com/samples/20380

Based on the ingredients, the segment consists of amino acids, vitamins minerals, botanical supplements, and others. Vitamins minerals are expected to emerge as one of the largest used ingredients in the weight loss dietary supplements. By the end of 2026, vitamins minerals are estimated to exceed US$ 16,900 million revenue.

Region-wise, the market is categorized into Europe, North America, Asia Pacific Excluding Japan (APEJ), Latin America, Japan, and the Middle East and Africa (MEA). Among the given regions, North America is expected to dominate the global weight loss dietary supplements market throughout the forecast period 2017-2026.

Global Weight Loss Dietary Supplements Market: Competitive Assessment

Key players in the global weight loss dietary supplements market are Amway (Nutrilite), Abott Laboratories, GlaxoSmithKline, Glanbia, Herbalife International, Pfizer, American Health, Stepan, Nature’s Sunshine Products, and FANCL.

Categories
Weight Loss Products

Fake Reviews? How the FTC Got Involved, Reached Settlement

The internet era has enabled millions of consumers to get the inside scoop on merchandise they intend to buy through reading online reviews left by prior purchasers. Many of those reviews were written by legitimate individuals sharing their experience with a particular product or service. However other responses may have been left by trolls or people who have been paid to leave certain types of feedback. Although various review controversies have been covered by the media over the past several years, the FTC has just now settled its first lawsuit regarding fake online reviews.

 

The focus of the FTC’s first successful outcome in cases involving false reviews was a company named Cure Encapsulations, Inc. This organization sells a product called Quality Encapsulations Garcinia Cambogia Extract with HCA. The formulation of that supplement was designed to enable users to lose weight through appetite suppression. The product’s manufacturer also claimed that it could effectively prevent the formation of fat cells. Like many supplements, it was not vetted by the FDA and it is not backed by any scientific testing or results.

 

Despite lacking scientific evidence, the product garnered many positive reviews on internet superstore Amazon. During the FTC’s investigation, it was discovered that many of those positive reviews were purchased from AmazonVerifiedReviews.com. Even before this case, many Amazon consumers have sought to avoid fake reviews by instead visiting websites that provide unbiased reviews including an examination of a product’s pros and cons.

 

Although not the same as prosecution or a lawsuit levied by a federal government agency, Amazon has previously sued firms, including the one used by Cure Encapsulations, for publishing false reviews on their site. Amazon has also investigated significant time and resources in ferreting out false reviews and removing them from their site. At this time, Amazon has blocked Cure Encapsulation from continuing to sell products on their site. The supplement company, which sells a majority of its products as an Amazon third-party retail, may soon find itself in an economically negative situation.

 

The company’s attorney, August Horvath, has pledged to work with Amazon to find an amicable solution. Horvath also says that the company has not solicited or benefitted from fake reviews since the middle of 2015. Nevertheless, the FTC pursued charges of deceptive marketing against the organization, both for fake reviews and making unscientifically based claims as to their product’s efficacy. Terms of the settlement reached have not been released and will likely be subject to non-disclosure agreements.